Category: Patent & Other IP Offices
-
‘Striking’ and ‘extremely rare’: Japanese patent community reacts to USPTO Director Squires Nintendo patent reexamination order
Sources in the Japanese patent community tell ip fray that a USPTO reexamination order over a Nintendo patent signals heightened attention of claims that may overreach into broad gameplay mechanics – although the order will have no impact on Nintendo’s ongoing patent infringement litigation against Pocketpair in Japan.
-
UPC CoA: translation of specification presumed accurate if it formed basis of EPO examination; court can decide added matter even without written argument
The UPC’s CoA affirmed the Dusseldorf LD’s finding of invalidity over added matter.
-
USPTO Director Squires orders rare Director-initiated ex parte reexamination of Nintendo patent, indirectly as result of games fray article
An article about the grant of a patent to Nintendo by games fray (one of ip fray’s two sibling sites), was picked up by many games media. It apparently got the USPTO’s attention.
-
AIA & AIA: Director Squires issues America’s Innovation Agency memo to take charge of IPR institution decisions under America Invents Act
USPTO Director John A. Squires wants to put an end to the PTAB’s tendency to institute IPRs for career and institutional motives.
-
USPTO Director Squires proposes rules that would marginalize PTAB IPRs: market value of “born strong” U.S. patents to rise
Director Squires has proposed new rules for the PTAB that do not merely complicate but simply prevent serial challenges to patent, even on different grounds. And not only that.
-
Samsung ordered to pay $445 million in U.S. wireless standards-related infringement dispute: jury verdict
The Eastern District of Texas has issued a jury verdict ordering Samsung to pay over $445 million in damages for infringing four of non-practising entity Collission’s wireless communication standard-essential patents.
-
Squires on fire: revived patent post-PTAB, declared expert unreliable, took procedural route that may have closed door to appeal
Based on an expert’s lack of credibility in his eyes, Director Squires not only terminated the PTAB proceedings without a remand but also made it difficult (or impossible) to appeal,
-
USPTO director Squires greenlights deputy Morgan Stewart’s PTAB discretionary denial program
John A. Squires, who took over as United States Patent and Trademark Office director last month, has issued a Delegation of Authority for deputy director Coke Morgan Stewart to continue the recently reinstated Patent Trial and Appeal Board discretionary denial program.
-
Federal Circuit partly grants Bayer second chance in defending rivaroxaban patent invalidation campaign
The Federal Circuit has partly affirmed and partly vacated a United States Patent and Trademark Office’s Patent Trial and Appeal Board decision that deemed one of Bayer’s rivaroxaban-related patents invalid, in a three-year case initiated by rivals Mylan Pharmaceuticals, Teva Pharmaceuticals, and Invagen Pharmaceuticals.
-
Novo Nordisk suffers loss over negative claim limitation in ongoing patent dispute over diabetes drug Wegovy
The United States District Court for the District of Delaware has ruled that Viatris has not induced the infringement of one of five asserted patents in litigation initiated by Novo Nordisk.